Below are potential future clinical trial dosages that might be explored for the combo of CJC-1295 (No-Dac) & Ipamorelin based on other research cited.

• 100 to 300 mcg per dose, administered subcutaneously 1 to 3x per day
• To be taken 5 days a week in 8 to 12 weeks cycles
• Administered on empty stomach in morning or before bedtime

*NOTE: This dosage schedule is for educational, and research use only. Products purchased from omegapeps.com have not been approved by the FDA for clinical studies or trials involving humans or animals at this time.